-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – NB-003 in Gastrointestinal Stromal Tumor (GIST)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - NB-003 in Gastrointestinal Stromal Tumor (GIST) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. NB-003 in Gastrointestinal Stromal Tumor (GIST) Drug Details: NB-003 is...
-
Sector Analysis
Enterprise IoT Market Trends and Analysis by Region, Product, Enterprise, Vertical, Connectivity and Segment Forecast to 2027
Accessing the in-depth insights from the ‘Enterprise IoT report can help: Gain a valuable understanding of the current and future state of the market, allowing businesses to make informed decisions about market entry, product development, and investments Identify competitors' capabilities to stay ahead in the market Identify segments and get an understanding of various stakeholders across different stages of the entire value chain Anticipate changes in demand and adjust the business development strategies Identify potential regions and countries for growth opportunities How is our ‘Enterprise...
-
Product Insights
NewBlood Glucose Meters Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Blood Glucose Meters Pipeline Market Report Overview A blood glucose meter is an electronic diabetic management device used for measuring blood glucose levels. Additionally, continuous glucose monitors are covered under this segment. The blood glucose meters pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials,...
-
Product Insights
NewKidney Fibrosis – Drugs In Development, 2024
Empower your strategies with our Kidney Fibrosis – Drugs In Development, 2024 report and make more profitable business decisions. Accumulation of extracellular matrix in the kidney causes kidney fibrosis. It is a progressive disorder characterized by glomerulosclerosis and tubulointerstitial fibrosis and may lead to detrimental effects on the kidney functioning. Predisposing factors are trauma, injury, infections, surgery, environmental factors, and exposure to chemicals or radiation. Symptoms include pain, problems related to urination, nausea, and vomiting. The condition may be managed with...
-
Product Insights
NewInsomnia – Drugs In Development, 2024
Empower your strategies with our Insomnia – Drugs In Development, 2024 report and make more profitable business decisions. Insomnia is a sleep disorder that is characterized by difficulty falling and/or staying asleep. Symptoms include difficulty falling asleep at night, irritability, depression or anxiety, tension headaches, and distress in the stomach and intestines. Risk factors include age, mental health disorder, stress, and shift working. The Insomnia drugs in development market research report provide comprehensive information on the therapeutics under development for Insomnia,...
-
Product Insights
NewGastrointestinal Tumor – Drugs In Development, 2024
Empower your strategies with our Gastrointestinal Tumor – Drugs In Development, 2024 report and make more profitable business decisions. Gastrointestinal (GI) tumors refer to abnormal growths or neoplasms that develop in various parts of the digestive system, which includes the esophagus, stomach, intestines (small and large), liver, gallbladder, and pancreas. These tumors can be benign (non-cancerous) or malignant (cancerous). The Gastrointestinal Tumor drugs in development market research report provide comprehensive information on the therapeutics under development for Gastrointestinal Tumor, complete with...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SBI-100 in Ocular Hypertension
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SBI-100 in Ocular Hypertension report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. SBI-100 in Ocular Hypertension Drug Details: NB-1111 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SBI-100 in Open-Angle Glaucoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SBI-100 in Open-Angle Glaucoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. SBI-100 in Open-Angle Glaucoma Drug Details: NB-1111 is under development for the...